Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.2K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

17.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation and Purification of RANKL-Derived Small-Fragment Variants for Osteoclast Inhibition.

Pharmaceutics·2025
Same author

Non-pyroptotic caspase-11 activity regulates osteoclastogenesis and pathological bone loss.

Cell death and differentiation·2025
Same author

Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice.

Nature communications·2025
Same author

Metformin reverses periodontal destruction caused by experimental periodontitis by inhibiting interleukin-1β activity.

Journal of periodontology·2025
Same author

Rac1-dependent regulation of osteoclast and osteoblast differentiation by developmentally regulated GTP-binding 2.

Cell death discovery·2025
Same author

The microbial metabolite imidazole propionate dysregulates bone homeostasis by inhibiting AMP-activated protein kinase (AMPK) signaling.

Communications biology·2024

Related Experiment Video

Updated: Jan 7, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.2K

MKRN1 Regulates RANKL-Induced Differentiation Via Akt and AMPK Pathways.

Inyoung Kim1,2, Jung Ha Kim1, Kabsun Kim1

  • 1Department of Pharmacology, Chonnam National University Medical School, Gwangju, Republic of Korea.

Journal of Cellular Physiology
|December 29, 2025
PubMed
Summary
This summary is machine-generated.

Makorin ring finger protein 1 (MKRN1) promotes osteoclast differentiation by regulating Akt and AMP-activated protein kinase (AMPK) signaling. MKRN1 deficiency increases bone volume, suggesting its therapeutic potential for bone diseases.

Keywords:
AMPKAktMKRN1osteoclast differentiation

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

9.1K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

597

Related Experiment Videos

Last Updated: Jan 7, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.2K
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

9.1K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

597

Area of Science:

  • Cell Biology
  • Bone Biology
  • Molecular Biology

Background:

  • Osteoclasts are crucial for bone resorption; understanding their regulation is key for treating bone diseases like osteoporosis.
  • Signaling pathways including Akt, MAPK, and NF-κB regulate osteoclast differentiation.
  • Makorin ring finger protein 1 (MKRN1) influences Akt and AMP-activated protein kinase (AMPK) signaling, but its role in osteoclasts is unknown.

Purpose of the Study:

  • To investigate the specific role of MKRN1 in osteoclast differentiation and bone metabolism.
  • To elucidate the molecular mechanisms by which MKRN1 affects osteoclastogenesis.
  • To assess the potential of MKRN1 as a therapeutic target for bone diseases.

Main Methods:

  • Overexpression and silencing of Mkrn1 in bone marrow-derived macrophages (BMMs).
  • Induction of osteoclast differentiation using receptor activator of nuclear factor kappa B (NF-κB) ligand (RANKL) and assessment via tartrate-resistant acid phosphatase (TRAP) staining.
  • Western blot analysis of Akt and AMPK phosphorylation.
  • Phenotypic analysis of Mkrn1-deficient mice.

Main Results:

  • MKRN1 overexpression enhanced RANKL-induced osteoclast differentiation by promoting Akt phosphorylation and inhibiting AMPK phosphorylation.
  • MKRN1 silencing impaired osteoclastogenesis by reducing Akt phosphorylation and increasing AMPK phosphorylation.
  • Mkrn1 deficiency in mice resulted in increased bone volume.

Conclusions:

  • MKRN1 acts as a positive regulator of osteoclast differentiation.
  • MKRN1 influences osteoclastogenesis through the Akt and AMPK signaling pathways.
  • MKRN1 is a potential therapeutic target for conditions involving excessive bone resorption, such as osteoporosis.